Current HIV/AIDS Reports

Papers
(The TQCC of Current HIV/AIDS Reports is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Adventures in COVID-19 Policy Modeling: Education Edition65
Spiraling Risk: Visualizing the multilevel factors that socially pattern HIV risk among gay, bisexual & other men who have sex with men using Complex Systems Theory50
Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review48
Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?47
Challenges and Opportunities in Big Data Science to Address Health Inequities and Focus the HIV Response43
Syndemic Theory and Its Use in Developing Health Interventions and Programming: A Scoping Review40
Feasibility and Impact of Community Pharmacy and Novel Pick-up Points for Antiretroviral Therapy Pre-exposure Prophylaxis Initiation and Continuation in Low and Middle-income Countries40
Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review32
Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic31
Ethical Perspectives in Using Technology-Enabled Research for Key HIV Populations in Rights-Constrained Settings28
Interventions to Improve Adolescent HIV Care Outcomes25
Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States25
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?24
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review22
More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure22
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa22
Consolidated Overview of Notifiable Adverse Events in the U.S. President’s Emergency Plan for AIDS Relief’s Voluntary Medical Male Circumcision Program Through 202022
Technology-Delivered Intervention Strategies to Bolster HIV Testing21
Risk Compensation in Voluntary Medical Male Circumcision Programs21
Intestinal Microbiota and Aging in People with HIV—What We Know and What We Don’t21
The Value of Assessing Self-Reported and Biological Indicators of Outcomes in Evaluating HIV Programs20
Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy20
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program19
Update on Central Nervous System Effects of HIV in Adolescents and Young Adults19
Voluntary Medical Male Circumcision for HIV Prevention: a Global Overview18
PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice18
A Review of Serious Gaming as an Intervention for HIV Prevention17
Transition to Adult Care for Young People Living with HIV17
Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV17
Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa15
Medicinal Plant and Traditional Knowledge-guided Strategies to Combat HIV Persistence15
VMMC Programmatic Successes and Challenges: Western Kenya Case Study15
Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions14
Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy14
Intervention Approaches to Address Intimate Partner Violence and HIV: a Scoping Review of Recent Research14
Update on Vaccination Recommendations for Adults with HIV14
HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently?14
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era13
Fatty Liver Disease: Enter the Metabolic Era13
Mpox and HIV: a Narrative Review13
Genomic Exploration of the Brain in People Infected with HIV—Recent Progress and the Road Ahead13
Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations12
PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa12
The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies12
Long-Acting Injectable Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus: A Review12
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups12
0.086458921432495